ASCO aims Big Data at cancer treatment

The American Society of Clinical Oncology is developing a database of cancer patients that could change the way doctors select treatments. With medical records on millions of people, the Big Data project could identify the best combination of drugs and other treatments for individual patients--provided researchers can figure out how to massage the information into useful forms while protecting patient privacy. Report (sub. req.)

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.